![Richard Kender](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Kender
Director/Board Member at LONGEVERON INC.
Net worth: 352 920 $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Eric Shaff | M | 48 | 10 years | |
Kevin Lee | M | 55 |
Bicycle Therapeutics, Inc.
![]() Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009.
BicycleTx Ltd.
![]() BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK. | 9 years |
Janice Bourque | F | 67 |
BicycleTx Ltd.
![]() BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK.
Bicycle Therapeutics, Inc.
![]() Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | 8 years |
Pierre Legault | M | 63 |
BicycleTx Ltd.
![]() BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK.
Bicycle Therapeutics, Inc.
![]() Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | 5 years |
Mohammed Khoso Baluch | M | 66 | 12 years | |
Veronica Jordan | M | 73 |
BicycleTx Ltd.
![]() BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK.
Bicycle Therapeutics, Inc.
![]() Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | 5 years |
Alistair Milnes | M | 51 | 3 years | |
Kate Bingham | F | 58 |
BicycleTx Ltd.
![]() BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK. | 8 years |
Mohamed Wa’el Ahmed Hashad | M | 61 | 3 years | |
Thomas Kuhn | M | 50 | 15 years | |
Pascale Fouqueray-Grellier | M | 61 | 15 years | |
Sebastien Bolze | M | - | 15 years | |
Michael Skynner | M | 55 |
Bicycle Therapeutics, Inc.
![]() Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | 8 years |
Mahesh Karande | M | 51 | 5 years | |
Barbara Y. Chan | F | 60 | - | |
Joshua Hare | M | 61 | 10 years | |
Stephen Berenson | M | 63 | 5 years | |
Gregory Winter | M | 73 |
BicycleTx Ltd.
![]() BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK. | 15 years |
Carlo Tanzi | M | - | 9 years | |
Tom Glocer | M | 63 | 17 years | |
Rainer Boehm | M | 63 | 2 years | |
Stephen Sands | M | 67 | - | |
Matthew Henn | M | 49 | 12 years | |
Neil Hare | M | 54 | 9 years | |
Ling Zeng | F | 55 | 2 years | |
David Ege | M | 50 | 21 years | |
Paul Lehr | M | 56 | 8 years | |
Ursula Ungaro | F | 73 | 3 years | |
Dalton Smart | M | 58 | 15 years | |
Travis Thompson | M | - | 6 years | |
Chirfi Guindo | M | 58 | 13 years | |
Gary O'Neill | M | - |
Abide Therapeutics, Inc.
![]() Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | 11 years |
Willard Dere | M | 70 | 7 years | |
Elliott Levy | M | 65 | 3 years | |
Patricia Russo | F | 71 | 29 years | |
John Mendlein | M | 64 | 4 years | |
Christian Schade | M | 63 | 1 years | |
Dennis Ausiello | M | 78 | 9 years | |
Mary Szela | F | 60 | 5 years | |
Thomas DesRosier | M | 69 | 8 years | |
Richard Young | M | 70 | 7 years | |
Jose-Carlos Gutiérrez-Ramos | M | 61 | 3 years | |
Claire Fraser-Liggett | M | 68 | 1 years | |
Kurt Graves | M | 56 | 9 years | |
Caroline Litchfield | F | 55 | 34 years | |
Lisa Locklear | F | 64 | 1 years | |
Pascale Boissel | F | 57 | 9 years | |
Sophie Hallakou-Bozec | M | - | 15 years | |
Paul Biondi | M | 54 | 4 years | |
Douglas Losordo | M | 65 | 3 years | |
Nicholas Keen | M | 56 | 7 years | |
Barbara McGovern | M | - | 9 years | |
Lisa McClain Moss | F | 53 | 7 years | |
Allan Gabor | M | - | 11 years | |
Brian Rash | M | - | 1 years | |
Steven Graziano | M | - | 18 years | |
Jennifer Perry | F | - | - | |
Nataliya Agafonova | M | 55 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert P. Luciano | M | - | 23 years | |
Richard Kogan | M | 81 | 21 years | |
Kenneth Frazier | M | 69 | 30 years | |
P. Vagelos | M | 94 | 19 years | |
Roger Pomerantz | M | 67 | 9 years | |
Marcus Chapman | M | 53 | 7 years | |
Lee Kalowski | M | 43 | 6 years | |
James Corbett | M | 65 |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | 4 years |
Myrtle Potter | F | 65 |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support.
FoxHollow Technologies, Inc.
![]() FoxHollow Technologies, Inc. Medical SpecialtiesHealth Technology FoxHollow Technologies, Inc. designs, develops, manufactures, and sells medical devices for the treatment of peripheral artery disease. The company's products include Rinspirator, Seath, and SilverHawk plaque excision system. Its products are used for disposable catheter system that removes plaque and reopens blocked arteries. The company was founded by John B. Simpson in October 1996 and is headquartered in Redwood City, CA. | 18 years |
David Berry | M | 47 | 5 years | |
Noubar Afeyan | M | 60 | 10 years | |
Fred Hassan | M | 78 | 6 years | |
Raymond Gilmartin | M | 82 | 2 years | |
John G. Aunins | M | 63 | 31 years | |
David Norton | M | 72 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | 2 years |
David Arkowitz | M | 62 | 7 years | |
Robert Palmisano | M | 79 |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | 2 years |
Richard Clark | M | 77 | 6 years | |
Lorence Kim | M | 49 | 6 years | |
Kevin J. Horgan | M | 64 | 8 years | |
Meryl Zausner | F | 67 | 5 years | |
Grégory Behar | M | 55 | 9 years | |
Laura Sepp-Lorenzino | M | 63 | 15 years | |
Linda Harty | F | 63 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | - |
Matthew Monaghan | M | 56 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | - |
David Burgstahler | M | 55 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | 7 years |
Richard Markham | M | 73 | 20 years | |
Charles Harwood | M | 70 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | 6 years |
Wendy Yarno | F | 68 | 9 years | |
William Klitgaard | M | 71 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | - |
James Bannon | M | 71 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | 4 years |
Rochelle Lazarus | F | 76 | 16 years | |
Thomas Shenk | M | 77 | 11 years | |
Ken Meyers | M | 62 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | - |
John J Horan | M | - | 6 years | |
David Anstice | M | 75 | 5 years | |
William Harrison | M | 80 | - | |
Wendell Weeks | M | 64 | 16 years | |
Duncan MacDonald | M | 56 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | 6 years |
Richard Henriques | M | 68 | 27 years | |
Caroline Dorsa | F | 64 | 22 years | |
Gerard Cunningham | M | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 86 | 86.00% |
United Kingdom | 14 | 14.00% |
France | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Kender
- Personal Network